Journals / Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi / 2022 / Cilt: 12 - Sayı: 4

Assciation of Acetylcholinesterase and Butyrylcholinesterase Enzymes with Alzheimer's Disease

Asetilkolinesteraz ve Bütirilkolinesteraz Enzimlerinin Alzheimer Hastalığı ile İlişkisi

Pages
2386–2395
Publication Date
2022-12-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, the association of AChE and BChE cholinesterase enzymes with Alzheimer's disease was evaluated.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Alzheimer's disease (AD) is a neurodegenerative disease that is mostly seen in the elderly population, is clinically characterized by memory and cognitive disorders, and causes irreversible damage to neuron cells.
📊
Key Findings & Data:Many reasons such as the unknown causes of the disease, the increase in the number of patients with the increase in life expectancy, the decrease in the quality of life of the disease, and the high cost of treatment have increased the importance of the disease and directed researchers to this field.
💡
Conclusion & Impact:In this study, the association of AChE and BChE cholinesterase enzymes with Alzheimer's disease was evaluated.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:AChE · BChE · Alzheimer hastalığı

Abstract

Alzheimer's disease (AD) is a neurodegenerative disease that is mostly seen in the elderly population, is clinically characterized by memory and cognitive disorders, and causes irreversible damage to neuron cells. Many reasons such as the unknown causes of the disease, the increase in the number of patients with the increase in life expectancy, the decrease in the quality of life of the disease, and the high cost of treatment have increased the importance of the disease and directed researchers to this field. Although the etiology of the disease is not clarified, some hypotheses try to explain the cause of the disease. These are the cholinergic hypothesis, the amyloid hypothesis, the tau hypothesis, and the oxidative stress hypothesis. The cholinergic hypothesis is the only hypothesis that explains the cause of Alzheimer's disease and is still accepted. According to the cholinergic hypothesis, the decrease in the amount of acetylcholine, an important neurotransmitter that increases learning and cholinergic activity in the nervous system, causes Alzheimer's disease. Acetylcholine is synthesized by the cholineacetyltransferase (ChAT) enzyme in the nervous system, and hydrolyzed by Acetylcholinesterase (AChE) and Butyrylcholinesterase (BChE) enzymes. In this study, the association of AChE and BChE cholinesterase enzymes with Alzheimer's disease was evaluated.

Özet

Alzheimer hastalığı (AH) daha çok yaşlı popülasyonda görülen, klinik olarak hafıza ve bilişsel bozukluklar ile karakterize olan, geri dönüşümü olmayan nöron hücrelerinin hasarına yol açan bir nörodejeneratif hastalıktır. Hastalığının sebeplerinin tam olarak bilinmemesi, yaşama suresinin artmasıyla birlikte hasta sayısının gittikçe artması, hastalığın yaşam kalitesini çok fazla düşürmesi, tedavi maliyetinin çok yüksek olması gibi birçok neden hastalığın önemini artırmış ve araştırmacıların bu alana yönlendirmiştir. Hastalığın etiyolojisinin aydınlatılmamasına rağmen bazı hipotezlerle hastalığın nedeni açıklamaya çalışılmaktadır. Bunlar kolinerjik hipotez, amiloid hipotezi, tau hipotezi ve oksidatif stres hipotezidir. Kolinerjik hipotezi Alzheimer hastalığını nedenini açıklayan ve halen kabul gören tek hipotezdir. Kolinerjik hipoteze göre sinir sisteminde öğrenme ve kolinerjik aktiviteyi artıran önemli bir nörotransmiter olan asetilkolin miktarının azalması Alzheimer’e sebep olmaktadır. Asetilkolin sinir siteminde kolinasetiltransferaz (ChAT) enzimi tarafından sentezlenir, Asetilkolinesteraz (AChE) ve Bütirilkolinesteraz (BChE) enzimi tarafından hidroliz edilir. Bu çalışmada AChE ve BChE kolinesteraz enzimlerinin Alzheimer hastalığı ile ilişkisi değerlendirilmiştir.

🔖

Cite This Article

DEMİR, Z., TÜRKAN, F. (2022). Assciation of Acetylcholinesterase and Butyrylcholinesterase Enzymes with Alzheimer's Disease. Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi, Cilt: 12 - Sayı: 4, 2386–2395. https://ajindex.com/articles/859896

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Akasofu S, Kimura M, Kosasa T, Sawada K, Ogura H, 2008. Study of Neuroprotection of Donepezil a Therapy for Alzheimer's Disease. Chemico-Biological İnteractions, 175(1-3): 222-226. Alzheimer Derneği. 2019. 2019 Alzheimer Hastalığı Gerçekleri ve Rakamları. Alzheimer ve Demans, 15 (3): 321-387.
  2. Anstey K, J. von Sanden, C, Salim A, O'Kearney R, 2007. Smoking as a Risk Factor For Dementia and Cognitive Decline: a Meta-Analysis of Prospective Studies. American Journal of Epidemiology, 166(4): 367-378.
  3. Arce MP, Rodríguez-Franco MI, Gonzalez-Munoz, GC, Pérez C, López B, Villarroya M, Conde S, 2009. Neuroprotective and Cholinergic Properties of Multifunctional Glutamic Acid Derivatives For the Treatment of Alzheimer’s Disease. Journal of Medicinal Chemistry, 52(22): 7249-7257.
  4. Bartus R T, Dean III R L, Beer B, & Lippa A S, (1982). The Cholinergic Hypothesis of Geriatric Memory Dysfunction. Science, 217(4558): 408-414.
  5. Berman H A, Yguerabide J, Taylor P, 1980. Fluorescence Energy Transfer on Acetylcholinesterase: Spatial Relationship Between Beripheral Site and Active Center. Biochemistry, 19(10): 2226-2235.
  6. Blackard Jr WG, Sood GK, Crowe, DR, Fallon MB, 1998. Tacrine: a Cause of Fatal Hepatotoxicity? Journal of Clinical Gastroenterology, 26(1): 57-59.
  7. Bourne Y, Taylor P, Bougis P E, Marchot P, 1999. Crystal Structure of Mouse Acetylcholinesterase: a Peripheral Site-Occluding Loop in a Tetrameric Assembly. Journal of Biological Chemistry, 274(5): 2963-2970.
  8. Clarke R, Smith AD, Jobst K A, Refsum H, Sutton L, Ueland P M, 1998.
  9. Folate, Vitamin B1, and Serum Total Homocysteine Evels in Confirmed Alzheimer Disease. Archives of Neurology, 55(11): 1449-1455. Contestabile A, 2011. The History of the Oholinergic Hypothesis. Behavioural Brain Research, 221(2): 334-340. Cummings J L, 2000. Cholinesterase İnhibitors: a New Class of Psychotropic Compounds. American Journal of Psychiatry, 157(1): 4-15.
  10. Gaugler J, James B, Johnson T, Marin A, Weuve J, 2019. Alzheimer’s Disease Facts and Figures. Alzheimers Dement 2019, 15(3): 321-87.
  11. Hardy J, Bogdanovic N, Winblad B, Portelius E, Andreasen N, Cedazo‐Minguez A, Zetterberg H, 2014. Pathways to Alzheimer's Disease. Journal of İnternal Medicine, 275(3): 296-303.
  12. Holzgrabe U, Kapková P, Alptüzün V, Scheiber J Kugelmann E, 2007. Targeting Acetylcholinesterase to Treat Neurodegeneration. Expert Opinion on Therapeutic Targets, 11(2): 161-179. Irmak Ş, 2021. Yeni̇ Kumari̇n Türevlerinin SH-SY5Y Hücre Hattı Üzerinde Anti-Alzheimer Etkilerin